HomeTagsWearable Device

Wearable Device

MC-Rx Formalizes Pharmacy Benefit Coverage for Theranica’s Nerivio®, Providing Millions of Covered Members Access to the Novel Drug-Free Migraine Therapeutic

Nerivio, a drug-free Remote Electrical Neuromodulation (REN) device for the acute treatment of migraine in patients 12 years and older.

Nerivio Acute Migraine Therapeutic Device Is Now Available to Veterans

Nerivio has shown clinical efficacy for episodic and chronic migraine, both in clinical trials and real-world evidence analyses reports Jason Sico, MD, Associate Professor of Neurology and Internal Medicine in Yale School of Medicine.

Remote Electrical Neuromodulation Reported As Viable Alternative to Drugs for Acute Migraine

Remote Electrical Neuromodulation: "This study signals a potentially significant shift in how we approach the acute treatment of migraine," said lead author Michael Marmura, MD, Headache Specialist at the Thomas Jefferson University Hospital in Philadelphia.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version